A Distinguished Researcher and Science Leader with Global Impact
Martin Hrabě de Angelis has long been a driving force in biomedical research. Since 2000, he has led the Institute of Experimental Genetics at Helmholtz Munich, and since 2020, he has also served as the center’s Research Director. In parallel, he holds the Chair of Experimental Genetics at the Technical University of Munich. His scientific work bridges genetics, epigenetics, diabetes, phenotyping, and data mining.
He is the founder of the German Mouse Clinic, founding director of the European research consortium INFRAFRONTIER ERIC, and board member and spokesperson of the German Center for Diabetes Research (DZD). In addition, he co-founded the M1 Munich Medicine Alliance, where he also serves on the board. With more than 500 scientific publications, Hrabě de Angelis ranks among the most internationally recognized experts in his field. His achievements have been honored with numerous awards, including the Paul Langerhans Medal – the highest distinction of the German Diabetes Society – as well as election to the National Academy of Sciences Leopoldina.
“I am honored to assume this responsibility at such a pivotal moment and to work with our outstanding teams on advancing the strategic development of Helmholtz Munich. Connecting our world-class basic research with all dimensions of Computational Health and translating it into application is a central priority for me,” said Martin Hrabě de Angelis.
Dr. Michael Frieser, Administrative Managing Director at Helmholtz Munich, added: “With Prof. Dr. Martin Hrabě de Angelis the Supervisory Board has appointed our ideal candidate to guide the center through the upcoming period. I value him as an exceptional scientist and a highly capable colleague, and I greatly look forward to working with him.”
Succession of Matthias Tschöp
Martin Hrabě de Angelis succeeds Matthias Tschöp, who has been elected President of LMU after more than a decade in leadership roles at Helmholtz Munich. The two have worked closely for many years to drive the center’s progress.
